{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:48:17Z","timestamp":1792144097770,"version":"4.4.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T00:00:00Z","timestamp":1365638400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003220","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T20:49:57Z","timestamp":1365713397000},"page":"e1003220","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":169,"title":["Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis"],"prefix":"10.1371","volume":"9","author":[{"given":"Daniela F.","family":"Angelini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Severa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana M.","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rosicarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Gasperini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Buttari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Mechelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Borsellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Battistini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"A Compston","year":"2008","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"A Nylander","year":"2012","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.it.2009.03.007","article-title":"EBV in MS: guilty by association?","volume":"30","author":"JD L\u00fcnemann","year":"2009","journal-title":"Trends Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-Barr virus infection and multiple sclerosis: a review","volume":"5","author":"A Ascherio","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1073858410381531","article-title":"The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis","volume":"17","author":"MP Pender","year":"2011","journal-title":"Neuroscientist"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"DA Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/BOR.0b013e3283535801","article-title":"Lupus and epstein-barr","volume":"24","author":"JA James","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"ref8","first-page":"505","article-title":"Herpesviruses and autoimmunity","volume":"9","author":"DN Posnett","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410170412","article-title":"Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis","volume":"17","author":"CV Sumaya","year":"1985","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"P Sundstr\u00f6m","year":"2004","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"LI Levin","year":"2005","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","article-title":"Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study","volume":"6","author":"B Banwell","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1212\/01.wnl.0000326576.91097.87","article-title":"Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis","volume":"71","author":"JD L\u00fcnemann","year":"2008","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1177\/1352458511410515","article-title":"Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins","volume":"17","author":"R Mechelli","year":"2011","journal-title":"Mult Scler"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"A Ascherio","year":"2001","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","article-title":"Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis","volume":"67","author":"JD L\u00fcnemann","year":"2010","journal-title":"Ann Neurol"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"e12496","DOI":"10.1371\/journal.pone.0012496","article-title":"an updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"AE Handel","year":"2010","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awl067","article-title":"Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis","volume":"129","author":"JD L\u00fcnemann","year":"2006","journal-title":"Brain"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2249.2003.02114.x","article-title":"Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis","volume":"132","author":"P H\u00f6llsberg","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI200523661","article-title":"Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis","volume":"115","author":"S Cepok","year":"2005","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/brain\/awn108","article-title":"Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis","volume":"131","author":"S Jilek","year":"2008","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/jnnp.2008.161018","article-title":"Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis","volume":"80","author":"MP Pender","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.4049\/jimmunol.1103100","article-title":"HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis","volume":"188","author":"S Jilek","year":"2012","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","article-title":"Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases","volume":"24","author":"MP Pender","year":"2003","journal-title":"Trends Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2","volume":"205","author":"JD L\u00fcnemann","year":"2008","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ni835","article-title":"A functional and structural basis for TCR cross-reactivity in multiple sclerosis","volume":"3","author":"HL Lang","year":"2002","journal-title":"Nat Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1093\/brain\/awr197","article-title":"Epstein-Barr virus in the multiple sclerosis brain: a controversial issue - report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria","volume":"134","author":"H Lassmann","year":"2011","journal-title":"Brain"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/brain\/awp296","article-title":"Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis","volume":"133","author":"LA Peferoen","year":"2010","journal-title":"Brain"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"SN Willis","year":"2009","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1750-3639.2009.00343.x","article-title":"Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients","volume":"20","author":"O Torkildsen","year":"2010","journal-title":"Brain Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","article-title":"Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis","volume":"74","author":"SA Sargsyan","year":"2010","journal-title":"Neurology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein Barr virus infection in the multiple sclerosis brain","volume":"204","author":"B Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","article-title":"Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation","volume":"69","author":"B Serafini","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref34","article-title":"Radioactive in situ hybridization for EBER supports presence of Epstein-Barr virus in the multiple sclerosis brain","author":"B Serafini","year":"2013","journal-title":"Brain"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1212\/WNL.0b013e31823ed057","article-title":"Association of innate immune activation with latent Epstein-Barr virus in active MS lesions","volume":"78","author":"JS Tzartos","year":"2012","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","article-title":"Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI","volume":"73","author":"RA Farrell","year":"2009","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/jnnp.2004.048504","article-title":"Epstein-Barr virus and disease activity in multiple sclerosis","volume":"76","author":"D Buljevac","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.176.1.157","article-title":"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies","volume":"176","author":"RJ Murray","year":"1992","journal-title":"J Exp Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.185.9.1605","article-title":"Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response","volume":"185","author":"NM Steven","year":"1997","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1182\/blood-2008-02-138040","article-title":"Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow","volume":"112","author":"U Palendira","year":"2008","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11591110-000000000-00000","article-title":"The mechanism of action of interferon-\u03b2 in relapsing multiple sclerosis","volume":"25","author":"BC Kieseier","year":"2011","journal-title":"CNS Drugs"},{"key":"ref42","first-page":"1","article-title":"Natalizumab: Bench to Bedside and Beyond","volume":"5","author":"R Rudick","year":"2012","journal-title":"Arch Neurol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo","volume":"79","author":"LL Laichalk","year":"2005","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1128\/JVI.74.7.3235-3244.2000","article-title":"The BFRF1 gene of Epstein-Barr virus encodes a novel protein","volume":"74","author":"A Farina","year":"2000","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"AD Hislop","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"EJ Wherry","year":"2007","journal-title":"Immunity"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1128\/JVI.00141-09","article-title":"Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection","volume":"83","author":"D Sauce","year":"2009","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","article-title":"EBV and systemic lupus erythematosus: a new perspective","volume":"174","author":"AJ Gross","year":"2005","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e1002328","DOI":"10.1371\/journal.ppat.1002328","article-title":"Exhausted cytotoxic control of Epstein-Barr virus in human lupus","volume":"7","author":"M Larsen","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/1352458511426816","article-title":"EBV-specific immune responses in patients with multiple sclerosis responding to IFN\u03b2 therapy","volume":"18","author":"M Comabella","year":"2012","journal-title":"Mult Scler J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/1352458510392263","article-title":"CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment","volume":"17","author":"G Frisullo","year":"2011","journal-title":"Mult Scler"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Means RE, Lang SM, Jung JU. (2007) Human gammaherpesvirus immune evasion strategies. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press. Chapter 31.","DOI":"10.1017\/CBO9780511545313.032"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/eji.200939761","article-title":"Intrathecal immune responses to EBV in early MS","volume":"40","author":"E Jaqui\u00e9ry","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneuroim.2008.03.001","article-title":"Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF","volume":"196","author":"C Malmestr\u00f6m","year":"2008","journal-title":"J Neuroimmunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"H Babbe","year":"2000","journal-title":"J Exp Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.0308689100","article-title":"Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood","volume":"101","author":"C Skulina","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrmicro2541","article-title":"Genome-virome interactions: examining the role of common viral infections in complex disease","volume":"9","author":"EF Foxman","year":"2011","journal-title":"Nature Rev Microbiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1670","article-title":"Extralymphatic virus sanctuaries as a consequence of potent T-cell activation","volume":"13","author":"M Recher","year":"2007","journal-title":"Nat Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00868517","article-title":"Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study","volume":"243","author":"J Lycke","year":"1996","journal-title":"J Neurol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.58.1.31","article-title":"A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS","volume":"58","author":"E Bech","year":"2002","journal-title":"Neurology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.autrev.2011.08.005","article-title":"Autoimmune disease: A role for new anti-viral therapies?","volume":"11","author":"DH Dreyfus","year":"2011","journal-title":"Autoimmun Rev"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"CH Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"R Magliozzi","year":"2007","journal-title":"Brain"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1073\/pnas.70.1.190","article-title":"Release of infectious Epstein-Barr virus by transformed marmoset leukocytes","volume":"70","author":"G Miller","year":"1973","journal-title":"Natl Acad Sci U S A"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1352458508097920","article-title":"Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis","volume":"15","author":"JW Lindsey","year":"2009","journal-title":"Mult Scler"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T08:01:09Z","timestamp":1540368069000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003220"}},"subtitle":[],"editor":[{"given":"Brian D.","family":"Evavold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,11]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003220","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,11]]}}}